|
시장보고서
상품코드
1375084
북미 의료용 경피 흡수 패치 시장 예측(-2028년) : 지역별 분석 - 유형별, 용도별, 유통 채널별North America Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and Distribution Channel |
||||||
북미 의료용 경피 흡수 패치 시장은 2023년 34억 9,863만 달러에서 2028년에는 43억 2,469만 달러로 성장할 것으로 예측됩니다. 2023년부터 2028년까지 CAGR은 4.3%로 추정됩니다.
담배 소비 증가가 북미 의료용 경피 흡수 패치 시장을 촉진
미국에서 담배는 질병, 장애, 사망의 심각한 원인 중 하나입니다. CDC가 2021년에 발표한 데이터에 따르면, 미국에서는 추정 약 2,830만 명의 성인이 담배를 피우고 있습니다. 미국에서는 매일 1,600명 가까이(18세 미만)가 처음으로 담배를 피우고, 50만명 가까이의 미국인이 간접흡연에 노출되어 ?은 나이에 사망합니다. 같은 소스에 따르면, 전자 담배는 중고생들 사이에서 가장 자주 사용되는 담배 제품입니다. CDC는 또한 미국이 성인의 흡연 관련 질환 치료에 매년 2,250억 달러 이상을 의료비에 소비하고 있다고 합니다.
니코틴 대체 요법(NRT)은 금연을 목표로 하는 사람들을 돕는 것으로 입증되었습니다. NRT는 니코틴 패치를 사용하고 적당한 양의 니코틴을 투여하여 금연 욕망을 완화합니다. 니코틴 패치를 붙이면 니코틴이 점차 피부에서 흡수됩니다. 의존도가 높은 흡연자는 가장 강력한 패치를 사용하고, 의존도가 낮은 흡연자는 적은 복용량을 사용할 수 있습니다. 급성 NRT 제형(검, 비강 스프레이, 경구 흡입기, 정제)에 대한 니코틴 패치의 결정적인 이점은 하루 종일 약물을 소비하는 것이 아니라 컴플라이언스가 간단하다는 것입니다.
따라서 담배 소비 증가는 니코틴 패치 수요 증가로 이어져 경피 의료 패치 시장의 성장을 가속합니다.
북미 의료용 경피 흡수 패치 시장 개요
북미 의료용 경피 흡수 패치 시장은 미국, 캐나다, 멕시코로 구분됩니다. 2022년 북미 의료용 경피 흡수 패치 시장에서 가장 큰 점유율을 차지한 것은 미국이었습니다. 만성 질환을 앓고 있는 환자 수 증가와 연구 개발의 주요 발전이 의료용 경피 흡수 패치 시장을 추진하고 있는 주요 요인입니다.
북미 의료용 경피 흡수 패치 시장의 수익과 예측(-2028년)(금액)
북미 의료용 경피 흡수 패치 시장의 세분화
북미 의료용 경피 흡수 패치 시장은 유형, 용도, 유통 채널, 국가로 구분됩니다.
유형별로는 단층 약물 접착제, 다층 약물 접착제, 저장소, 증기 패치, 매트릭스로 구분됩니다. 2023년에는 매트릭스 부문이 가장 큰 시장 점유율을 기록했습니다.
용도별로는 신경 질환, 통증 관리, 니코틴 금연, 심혈관 장애, 호르몬 요법 등으로 구분됩니다. 통증 관리 부문가 2023년에 가장 큰 시장 점유율을 차지했습니다.
유통 채널별로는 북미 의료용 경피 흡수 패치 시장은 병원 약국, 소매 약국, 온라인 약국으로 구분됩니다. 병원 약국 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.
국가별로는 미국, 캐나다, 멕시코로 구분됩니다. 미국은 2023년 시장 점유율을 독점했습니다.
Boehringer Ingelheim International GmbH, Corium, LLC, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., UCB SA, Viatris Inc.가 이 지역의 의료용 경피 흡수 패치 시장에서 사업을 전개하고 있는 주요 기업입니다.
목차
제1장 서론
제2장 의료용 경피 흡수 패치 시장 - 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 북미 의료용 경피 흡수 패치 시장 - 시장 상황
- 개관
- PEST 분석
- 북미의 PEST 분석
- 전문가의 견해
제5장 북미 의료용 경피 흡수 패치 시장 : 주요 시장 역학
- 시장 성장 촉진요인
- 만성질환 유병률 증가
- 담배 소비 증가
- 시장 성장 억제요인
- 약제의 결함에 의한 의료용 경피 흡수 패치 리콜
- 시장 기회
- 전략적 이니셔티브 증가
- 향후의 동향
- 스마트 패치와 3D 프린팅 패치의 진보
- 영향 분석
제6장 의료용 경피 흡수 패치 시장 : 북미 분석
- 북미 의료용 경피 흡수 패치 시장의 수익 예측과 분석
제7장 북미 의료용 경피 흡수 패치 시장 : 유형별 수익과 예측(-2028년)
- 소개
- 의료용 경피 흡수 패치 시장의 유형별 수익 점유율(2022년, 2028년)
- 단층형 약물 접착제
- 다층 약물 접착제
- 리저버
- 증기 패치
- 매트릭스
제8장 북미 의료용 경피 흡수 패치 시장 : 용도별 수익과 예측(-2028년)
- 소개
- 의료용 경피 흡수 패치 시장의 용도별 매출액 점유율(2022년, 2028년)
- 신경질환
- 통증 관리
- 니코틴 중단
- 심혈관 질환
- 호르몬 요법
- 기타
제9장 북미 의료용 경피 흡수 패치 시장 : 판매 채널별 수익과 예측(-2028년)
- 소개
- 의료용 경피 흡수 패치 시장의 유통 채널별 수익 점유율(2022년, 2028년)
- 병원 약국
- 소매 약국
- 온라인 약국
제10장 의료용 경피 흡수 패치 시장 : 수익과 예측(-2028년) - 국가별 분석
- 북미
제11장 업계 상황
- 소개
- 성장 전략
- 개요
제12장 기업 프로파일
- Hisamitsu Pharmaceutical Co Inc
- Medline Industries LP
- Johnson & Johnson
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- UCB SA
- Viatris Inc
- Endo Pharmaceuticals Inc
- Boehringer Ingelheim International GmbH
- Corium, LLC.
제13장 부록
JHS 23.11.17The North America transdermal medical patch market is expected to grow from US$ 3,498.63 million in 2023 to US$ 4,324.69 million by 2028. It is estimated to register a CAGR of 4.3% from 2023 to 2028.
Growing Consumption of Tobacco Fuels North America Transdermal Medical Patch Market
In the US, tobacco is one of the significant causes of disease, disability, and death. According to the data published by CDC in 2021, an estimated 28.3 million adults smoke cigarettes in the US. Nearly 1,600 people (younger than 18 years) smoke their first cigarette every day in the US, and nearly half a million Americans die prematurely due to secondhand smoke exposure. As per the same source, e-cigarettes are the most frequently used tobacco products among high and middle school students. CDC also states that the US spends more than US$ 225 billion on medical care each year to treat smoking-related diseases in adults.
Nicotine replacement therapy (NRT) has proven to help people seeking to quit smoking. It makes use of nicotine patches that deliver modest nicotine dosages to relieve cravings. Nicotine is progressively absorbed through the skin once nicotine patches are applied. Smokers with a greater dependence level can use the most robust patches, while those with a lower dependence level can use a lesser dosage. The critical advantage of nicotine patches over acute NRT formulations (gum, nasal spray, oral inhaler, and tablet) is the simplicity of compliance, rather than consuming a medicine throughout the day.
Thus, the increasing consumption of tobacco leads to increasing demand for nicotine patches, thereby driving the growth of the transdermal medical patch market.
North America Transdermal Medical Patch Market Overview
The North American transdermal medical patch market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America transdermal medical patch market. The rising number of patients suffering from chronic conditions and increasing activities in research and development are the key factors propelling the market for transdermal medical patches.
North America Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)
North America Transdermal Medical Patch Market Segmentation
The North America transdermal medical patch market is segmented into type, application, distribution channel, and country.
Based on type, the market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch, and matrix. The matrix segment registered the largest market share in 2023.
Based on application, the market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.
Based on distribution channel, the North America transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.
Based on country, the North America transdermal medical patch market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.
Boehringer Ingelheim International GmbH, Corium, LLC, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America transdermal medical patch market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the transdermal medical patch market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Study Scope
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 North America Transdermal Medical Patch Market - by Type
- 1.3.2 North America Transdermal Medical Patch Market - by Application
- 1.3.3 North America Transdermal Medical Patch Market - by Distribution Channel
- 1.3.4 North America Transdermal Medical Patch Market - by Country
2. Transdermal Medical Patch Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Transdermal Medical Patch Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.3 Expert's Opinion
5. North America Transdermal Medical Patch Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Consumption of Tobacco
- 5.2 Market Restraints
- 5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
- 5.3 Market Opportunities
- 5.3.1 Increasing Strategic Initiatives
- 5.4 Future Trends
- 5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
- 5.5 Impact analysis
6. Transdermal Medical Patch Market - North America Analysis
- 6.1 North America Transdermal Medical Patch Market Revenue Forecast and Analysis
7. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Type
- 7.1 Overview
- 7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
- 7.3 Single-Layer Drug In-Adhesive
- 7.3.1 Overview
- 7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Multi-Layer Drug In-Adhesive
- 7.4.1 Overview
- 7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Reservoir
- 7.5.1 Overview
- 7.5.2 Reservoir: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Vapor Patch
- 7.6.1 Overview
- 7.6.2 Vapor Patch: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 7.7 Matrix
- 7.7.1 Overview
- 7.7.2 Matrix: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Application
- 8.1 Overview
- 8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
- 8.3 Neurologic Conditions
- 8.3.1 Overview
- 8.3.2 Neurologic Conditions: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Pain Management
- 8.4.1 Overview
- 8.4.2 Pain Management: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Nicotine Cessation
- 8.5.1 Overview
- 8.5.2 Nicotine Cessation: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.6 Cardiovascular Disorders
- 8.6.1 Overview
- 8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.7 Hormonal Therapy
- 8.7.1 Overview
- 8.7.2 Hormonal Therapy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Distribution Channels
- 9.1 Overview
- 9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
- 9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Retail Pharmacies
- 9.4.1 Overview
- 9.4.2 Retail Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Online Pharmacies
- 9.5.1 Overview
- 9.5.2 Online Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
10. Transdermal Medical Patch Market - Revenue and Forecast to 2028 - Country Analysis
- 10.1 North America: Transdermal Medical Patch Market
- 10.1.1 The Overview
- 10.1.2 North America: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
- 10.1.2.1 US: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.1.1 Overview
- 10.1.2.1.2 US: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.1.3 US: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.1.4 US: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.1.5 US: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.2 Canada: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.2.1 Overview
- 10.1.2.2.2 Canada: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.2.3 Canada: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.2.4 Canada: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.2.5 Canada: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.3 Mexico: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.3.1 Overview
- 10.1.2.3.2 Mexico: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.3.3 Mexico: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.3.4 Mexico: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.3.5 Mexico: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.1 US: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
11. Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies
- 11.2.1 Overview
12. Company Profiles
- 12.1 Hisamitsu Pharmaceutical Co Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Medline Industries LP
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Johnson & Johnson
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Novartis AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 UCB SA
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Viatris Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Endo Pharmaceuticals Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Boehringer Ingelheim International GmbH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Corium, LLC.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
